title: Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
abstract: Inactivation of the growth factor-regulated S6 kinase RSK2 causes Coffin-Lowry syndrome in humans, an X-linked mental retardation condition associated with progressive skeletal abnormalities. Here we show that mice lacking RSK2 develop a progressive skeletal disease, osteopenia due to impaired osteoblast function and normal osteoclast differentiation. The phenotype is associated with decreased expression of Phex, an endopeptidase regulating bone mineralization. This defect is probably not mediated by RSK2-dependent phosphorylation of c-Fos on serine 362 in the C-terminus. However, in the absence of RSK2, c-Fos-dependent osteosarcoma formation is impaired. The lack of c-Fos phosphorylation leads to reduced c-Fos protein levels, which are thought to be responsible for decreased proliferation and increased apoptosis of transformed osteoblasts. Therefore, RSK2-dependent stabilization of c-Fos is essential for osteosarcoma formation in mice and may also be important for human osteosarcomas.
authors.affiliation: Research Institute of Molecular Pathology, Vienna, Austria.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: David
authors.forename: Denis
authors.initials: D
authors.lastname: Mehic
authors.forename: Latifa
authors.initials: L
authors.lastname: Bakiri
authors.forename: Arndt F
authors.initials: AF
authors.lastname: Schilling
authors.forename: Vice
authors.initials: V
authors.lastname: Mandic
authors.forename: Matthias
authors.initials: M
authors.lastname: Priemel
authors.forename: Maria Helena
authors.initials: MH
authors.lastname: Idarraga
authors.forename: Markus O
authors.initials: MO
authors.lastname: Reschke
authors.forename: Oskar
authors.initials: O
authors.lastname: Hoffmann
authors.forename: Michael
authors.initials: M
authors.lastname: Amling
authors.forename: Erwin F
authors.initials: EF
authors.lastname: Wagner
mesh_terms: D000818:Animals; D001851:Bone Diseases, Metabolic / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D001842:Bone and Bones / Q000166:cytology / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation / Q000502:physiology; D002478:Cells, Cultured; D038921:Coffin-Lowry Syndrome / Q000235:genetics; D005260:Female; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D010006:Osteoblasts / Q000166:cytology / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology / Q000502:physiology; D012516:Osteosarcoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics / Q000378:metabolism*; D011859:Radiography; D038744:Ribosomal Protein S6 Kinases, 90-kDa / Q000235:genetics / Q000378:metabolism*
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D038744:Ribosomal Protein S6 Kinases, 90-kDa; C069330:ribosomal protein S6 kinase, 90kDa, polypeptide 3
references.citation: Nat Genet. 1995 Oct;11(2):130-6
references.pmid: 7550339
references.citation: EMBO J. 1995 Oct 16;14(20):5048-59
references.pmid: 7588633
references.citation: Cancer Res. 1995 Dec 15;55(24):6244-51
references.pmid: 8521421
references.citation: Oncogene. 1996 Apr 4;12(7):1493-502
references.pmid: 8622865
references.citation: J Biol Chem. 1996 Oct 11;271(41):25715-21
references.pmid: 8810350
references.citation: FEBS Lett. 1997 Feb 3;402(2-3):121-3
references.pmid: 9037179
references.citation: Hum Mol Genet. 1997 Feb;6(2):165-71
references.pmid: 9063736
references.citation: Endocrinology. 1997 Dec;138(12):5427-33
references.pmid: 9389528
references.citation: J Clin Endocrinol Metab. 1998 Oct;83(10):3459-62
references.pmid: 9768646
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12202-7
references.pmid: 9770464
references.citation: Nat Med. 2000 Sep;6(9):980-4
references.pmid: 10973316
references.citation: J Bone Miner Res. 2000 Aug;15(8):1440-50
references.pmid: 10934642
references.citation: Mol Cell. 2000 Jun;5(6):905-15
references.pmid: 10911985
references.citation: EMBO J. 2000 May 2;19(9):2056-68
references.pmid: 10790372
references.citation: Calcif Tissue Int. 2000 Apr;66(4):282-7
references.pmid: 10742446
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2462-7
references.pmid: 10716983
references.citation: Science. 1999 Nov 12;286(5443):1309-10
references.pmid: 10610536
references.citation: Endocrinology. 1999 Nov;140(11):4982-7
references.pmid: 10537122
references.citation: Mol Cell Biol. 2001 Jan;21(1):81-7
references.pmid: 11113183
references.citation: Endocrinology. 2001 Feb;142(2):926-39
references.pmid: 11159866
references.citation: Oncogene. 2001 Apr 30;20(19):2401-12
references.pmid: 11402336
references.citation: Oncogene. 2001 Nov 8;20(51):7563-72
references.pmid: 11709728
references.citation: Nature. 2002 Apr 18;416(6882):744-9
references.pmid: 11961557
references.citation: Dev Cell. 2002 Apr;2(4):389-406
references.pmid: 11970890
references.citation: Toxicol Pathol. 2002 May-Jun;30(3):312-21
references.pmid: 12051548
references.citation: Nat Cell Biol. 2002 Aug;4(8):556-64
references.pmid: 12134156
references.citation: J Med Genet. 2002 Oct;39(10):705-13
references.pmid: 12362025
references.citation: J Cell Sci. 2002 Nov 15;115(Pt 22):4317-25
references.pmid: 12376563
references.citation: Oncogene. 2003 Mar 13;22(10):1461-74
references.pmid: 12629509
references.citation: Bone. 2003 Apr;32(4):364-71
references.pmid: 12689679
references.citation: Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9
references.pmid: 12791601
references.citation: J Neurosci. 2003 Oct 8;23(27):9116-22
references.pmid: 14534245
references.citation: Nat Rev Cancer. 2003 Nov;3(11):859-68
references.pmid: 14668816
references.citation: Cell. 2004 Apr 30;117(3):387-98
references.pmid: 15109498
references.citation: Cell. 1995 Sep 8;82(5):721-32
references.pmid: 7545543
references.citation: Science. 1994 Oct 21;266(5184):443-8
references.pmid: 7939685
references.citation: Nature. 1994 Sep 8;371(6493):171-5
references.pmid: 8072547
references.citation: J Cell Biol. 1993 Aug;122(3):685-701
references.pmid: 8335693
references.citation: Nature. 1992 Dec 24-31;360(6406):741-5
references.pmid: 1465144
references.citation: J Bone Miner Res. 1987 Dec;2(6):595-610
references.pmid: 3455637
references.citation: Oncogene. 1989 Jul;4(7):861-5
references.pmid: 2547184
references.citation: Cell. 1992 Nov 13;71(4):577-86
references.pmid: 1423615